Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seonghae Yoon

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
International Journal of Antimicrobial Agents|May 29, 2016
Effectiveness of increasing the frequency of posaconazole syrup administration to achieve optimal plasma concentrations in patients with haematological malignancyWan Beom Park, Joo-Youn Cho, Sang-In Park, et al.
Lung Cancer (Amsterdam, Netherlands)|August 27, 2019
Safety, tolerability, and anti-tumor activity of olmutinib in non-small cell lung cancer with T790M mutation: A single arm, open label, phase 1/2 trialDong-Wan Kim, Dae Ho Lee, Ji-Youn Han, et al.
International Journal of Medical Informatics|February 16, 2021
Impact of a computerised clinical decision support system on vancomycin loading and the risk of nephrotoxicityJune Young Chun, Kyoung-Ho Song, Dong-Eun Lee, et al.
Cancer Medicine|March 27, 2018
A phase 4 study of nilotinib in Korean patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTKoreaJunghoon Shin, Youngil Koh, Seo Hyun Yoon, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
International Journal of Antimicrobial Agents|May 29, 2016
Effectiveness of increasing the frequency of posaconazole syrup administration to achieve optimal plasma concentrations in patients with haematological malignancyWan Beom Park, Joo-Youn Cho, Sang-In Park, et al.
Lung Cancer (Amsterdam, Netherlands)|August 27, 2019
Safety, tolerability, and anti-tumor activity of olmutinib in non-small cell lung cancer with T790M mutation: A single arm, open label, phase 1/2 trialDong-Wan Kim, Dae Ho Lee, Ji-Youn Han, et al.
International Journal of Medical Informatics|February 16, 2021
Impact of a computerised clinical decision support system on vancomycin loading and the risk of nephrotoxicityJune Young Chun, Kyoung-Ho Song, Dong-Eun Lee, et al.
Cancer Medicine|March 27, 2018
A phase 4 study of nilotinib in Korean patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTKoreaJunghoon Shin, Youngil Koh, Seo Hyun Yoon, et al.
Pageof 5